SCHEMBL22015459

SCHEMBL22015459

OCCOCCOCCOCCOc1ccc(-c2nc3ccccc3s2)cc1F

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 9/20 0.51
NPC1 O15118 6/20 0.51
KDM4E B2RXH2 6/20 0.51
SMN1; SMN2 Q16637 6/20 0.51
TP53 P04637 5/20 0.51
ALDH1A1 P00352 4/20 0.51
KMT2A Q03164 3/20 0.51
GLA P06280 3/20 0.51
HPGD P15428 2/20 0.51
BLM P54132 2/20 0.51
HSD17B10 Q99714 2/20 0.51
MEN1 O00255 2/20 0.51
HCRTR1 O43613 1/20 0.51
MAPK1 P28482 1/20 0.51
NPSR1 Q6W5P4 1/20 0.51
FFAR1 O14842 1/20 0.51
PPARD Q03181 1/20 0.51
PPARA Q07869 1/20 0.51
RAB9A P51151 7/20 0.49
POLB P06746 4/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25713690 0.89 KDM4E (0.51) MAPTNPC1KDM4ESMN1; SMN2TP53
SCHEMBL22015994 0.88 MAPT (0.53) MAPTNPC1KDM4ESMN1; SMN2TP53
SCHEMBL22015638 0.88 PTGS1 (0.54) MAPTNPC1KDM4ESMN1; SMN2TP53
SCHEMBL22015466 0.88 APP (0.53) MAPTNPC1KDM4ESMN1; SMN2TP53
SCHEMBL22015453 0.88 MAPT (0.50) MAPTNPC1KDM4ESMN1; SMN2TP53
SCHEMBL22015767 0.87 KDM4E (0.47) MAPTNPC1KDM4ESMN1; SMN2TP53
SCHEMBL22015632 0.86 MAPT (0.49) MAPTNPC1KDM4ESMN1; SMN2TP53
SCHEMBL22015996 0.86 SMN1; SMN2 (0.51) MAPTNPC1KDM4ESMN1; SMN2TP53
SCHEMBL22015837 0.86 KDM4E (0.48) MAPTNPC1KDM4ESMN1; SMN2TP53
SCHEMBL22015461 0.85 HDAC1 (0.49) MAPTNPC1KDM4ESMN1; SMN2TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220017477-A1 BENZOTHIAZOLE AND RELATED COMPOUNDS SPINOGENIX, INC. 2022-01-20 US disclosed
US-11117878-B2 Benzothiazole and related compounds SPINOGENIX, INC. (US) 2021-09-14 US disclosed
US-20200157068-A1 BENZOTHIAZOLE AND RELATED COMPOUNDS SPINOGENIX, INC. 2020-05-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220017477-A1 BENZOTHIAZOLE AND RELATED COMPOUNDS BACE1, APP, BACE2 MAPT 5/4885NPC1 1283/4885KDM4E 3807/4885
US-11117878-B2 Benzothiazole and related compounds BACE1, APP, BACE2 MAPT 5/4885NPC1 1283/4885KDM4E 3807/4885
US-20200157068-A1 BENZOTHIAZOLE AND RELATED COMPOUNDS BACE1, APP, BACE2 MAPT 5/4885NPC1 1283/4885KDM4E 3807/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.